Flatiron Health, a leading healthcare technology company headquartered in the United States, was founded in 2012 with a mission to improve cancer care through data-driven insights. The company operates primarily in the oncology sector, focusing on harnessing real-world evidence to enhance treatment outcomes and streamline clinical research. Flatiron Health's core offerings include its electronic health record (EHR) platform, which uniquely integrates clinical data with advanced analytics, enabling healthcare providers and researchers to make informed decisions. Notable achievements include partnerships with major pharmaceutical companies and a significant role in advancing precision medicine. With a strong market position, Flatiron Health continues to be at the forefront of transforming cancer care, leveraging technology to support both clinicians and patients in their journey through treatment.
How does Flatiron Health's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Flatiron Health's score of 78 is higher than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Flatiron Health, headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company is a current subsidiary of Roche Holding AG, which may influence its climate commitments and reporting practices. Flatiron Health has not established its own reduction targets or initiatives, nor does it have specific climate pledges documented. However, it is important to note that any potential climate commitments or emissions data may be inherited from its parent company, Roche Holding AG. This relationship suggests that Flatiron Health may align with Roche's sustainability strategies and targets, although specific details on these initiatives are not provided. As a part of the healthcare industry, Flatiron Health is positioned within a sector increasingly focused on reducing carbon footprints and enhancing sustainability practices. The lack of direct emissions data highlights an opportunity for the company to develop and communicate its climate commitments more transparently in the future.
Access structured emissions data, company-specific emission factors, and source documents
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 403,136,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 188,924,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Flatiron Health is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.